Acurx Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $843.9K | $13.3M | $13.0M |
| FY2022 | $2.1M | $9.4M | $9.1M |
| FY2023 | $3.0M | $7.7M | $7.5M |
| FY2024 | $3.2M | $3.9M | $3.7M |
| FY2025 | $2.4M | $7.7M | $7.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $843.9K | $13.3M | $13.0M |
| FY2022 | $2.1M | $9.4M | $9.1M |
| FY2023 | $3.0M | $7.7M | $7.5M |
| FY2024 | $3.2M | $3.9M | $3.7M |
| FY2025 | $2.4M | $7.7M | $7.6M |